3,324
Views
11
CrossRef citations to date
0
Altmetric
Review

COVID-19 and diabetes mellitus: implications for prognosis and clinical management

Pages 227-236 | Received 13 Apr 2020, Accepted 22 May 2020, Published online: 08 Jun 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Thomas M. Barber & Martin O. Weickert. (2021) How might remote management of diabetes mellitus during the COVID-19 pandemic impact patient care?. Expert Review of Endocrinology & Metabolism 16:4, pages 155-158.
Read now

Articles from other publishers (10)

Thijs van Rens, Petra Hanson, Oyinlola Oyebode, Lukasz Walasek, Thomas M Barber & Lena Al-Khudairy. (2022) Healthy diets, lifestyle changes and well-being during and after lockdown: longitudinal evidence from the West Midlands. BMJ Nutrition, Prevention & Health 5:2, pages 321-331.
Crossref
Andreea Fitero, Simona Gabriela Bungau, Delia Mirela Tit, Laura Endres, Shamim Ahmad Khan, Alexa Florina Bungau, Ioana Romanul, Cosmin Mihai Vesa, Andrei-Flavius Radu, Alexandra Georgiana Tarce, Mihaela Alexandra Bogdan, Aurelia Cristina Nechifor & Nicoleta Negrut. (2022) Comorbidities, Associated Diseases, and Risk Assessment in COVID-19—A Systematic Review. International Journal of Clinical Practice 2022, pages 1-24.
Crossref
Prakash Gangadaran, Himabindu Padinjarathil, Shri Hari Subhashri Rajendran, Manasi P Jogalekar, Chae Moon Hong, Baladhandapani Aruchamy, Uma Maheswari Rajendran, Sridharan Gurunagarajan, Anand Krishnan, Prasanna Ramani & Kavimani Subramanian. (2022) COVID-19 and diabetes: What do we know so far?. Experimental Biology and Medicine 247:15, pages 1330-1334.
Crossref
Fadhel A. Alomar, Marai N. Alshakhs, Salah Abohelaika, Hassan M. Almarzouk, Mohammed Almualim, Amein K. Al-Ali, Fahad Al-Muhanna, Mohammed F. Alomar, Mousa J. Alhaddad, Mohammed S. Almulaify, Faisal S. Alessa, Ahmed S. Alsalman, Ahmed Alaswad, Sean R. Bidasee, Hassan A. Alsaad, Rudaynah A. Alali, Mona H. AlSheikh, Mohammed S. Akhtar, Mohammed Al Mohaini, Abdulkhaliq J. Alsalman, Hussain Alturaifi & Keshore R. Bidasee. (2022) Elevated plasma level of the glycolysis byproduct methylglyoxal on admission is an independent biomarker of mortality in ICU COVID-19 patients. Scientific Reports 12:1.
Crossref
Eduardo M. LacapJrJr, Abraham Varghese, Faryal Khamis, Maher Al Bahrani, Hamed Al Naamani, Shajidmon Kolamban, Samata Al Dowaiki & Huda Salim Al Shuaily. (2022) Development and validation of the CoV19-OM intensive care unit score: An early ICU identification for laboratory-confirmed SARS-CoV-2 patients from a retrospective cohort study in Oman. International Journal of Infectious Diseases 117, pages 241-246.
Crossref
Sian A. Bradley, Maciej Banach, Negman Alvarado, Ivica Smokovski & Sonu M. M. Bhaskar. (2021) Prevalence and impact of diabetes in hospitalized COVID‐19 patients: A systematic review and meta‐analysis . Journal of Diabetes 14:2, pages 144-157.
Crossref
Liping Yang, Jing Yang, Jian He, Yan Zhou, Yangyang Zhang, Bin Sun, Jing Gao & Liting Qian. (2021) Analysis of Anxiety and Depression Status in Patients Undergoing Radiotherapy During the COVID-19 Epidemic. Frontiers in Psychiatry 12.
Crossref
Philip T James, Zakari Ali, Andrew E Armitage, Ana Bonell, Carla Cerami, Hal Drakesmith, Modou Jobe, Kerry S Jones, Zara Liew, Sophie E Moore, Fernanda Morales-Berstein, Helen M Nabwera, Behzad Nadjm, Sant-Rayn Pasricha, Pauline Scheelbeek, Matt J Silver, Megan R Teh & Andrew M Prentice. (2021) The Role of Nutrition in COVID-19 Susceptibility and Severity of Disease: A Systematic Review. The Journal of Nutrition 151:7, pages 1854-1878.
Crossref
Thomas M. Barber, Ioannis Kyrou, Harpal S. Randeva & Martin O. Weickert. (2021) Mechanisms of Insulin Resistance at the Crossroad of Obesity with Associated Metabolic Abnormalities and Cognitive Dysfunction. International Journal of Molecular Sciences 22:2, pages 546.
Crossref
Martin O. Weickert, Tim Robbins, Ioannis Kyrou, Adam Hopper, Eilish Pearson, Thomas M. Barber, Gregory Kaltsas & Harpal S. Randeva. (2021) Impact of the COVID-19 pandemic on neuroendocrine tumour services in England. Endocrine 71:1, pages 14-19.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.